tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PFE Stock Latest News

Pfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for Infant RSV Protection
Company AnnouncementsPfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for Infant RSV Protection
10h ago
PFE
Pfizer’s Study on Rimegepant and Pregnancy: What Investors Need to Know
PremiumCompany Announcements
Pfizer’s Study on Rimegepant and Pregnancy: What Investors Need to Know
10h ago
PFE
Pfizer’s New Phase 1 Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Pfizer’s New Phase 1 Study: A Potential Game-Changer in Cancer Treatment?
10h ago
PFE
Pfizer’s New Study on COVID-19 Vaccine Effectiveness: What Investors Need to Know
PremiumCompany Announcements
Pfizer’s New Study on COVID-19 Vaccine Effectiveness: What Investors Need to Know
10h ago
PFE
Pfizer’s Inclacumab Study: A Potential Game-Changer for Sickle Cell Disease
PremiumCompany Announcements
Pfizer’s Inclacumab Study: A Potential Game-Changer for Sickle Cell Disease
10h ago
PFE
Pfizer’s Latest Study on HER2-positive Breast Cancer Treatment: Key Insights for Investors
PremiumCompany AnnouncementsPfizer’s Latest Study on HER2-positive Breast Cancer Treatment: Key Insights for Investors
10h ago
PFE
Pfizer’s Promising Migraine Study in Adolescents: What Investors Should Know
Premium
Company Announcements
Pfizer’s Promising Migraine Study in Adolescents: What Investors Should Know
10h ago
PFE
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Potential Game-Changer
Premium
Company Announcements
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Potential Game-Changer
10h ago
PFE
Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema
PremiumCompany Announcements
Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema
10h ago
PFE
Pfizer’s Rimegepant Study: A Potential Game-Changer in Migraine Prevention
PremiumCompany Announcements
Pfizer’s Rimegepant Study: A Potential Game-Changer in Migraine Prevention
10h ago
PFE
Pfizer’s Ongoing Study on COMIRNATY Vaccine Safety in Youth: Key Insights for Investors
PremiumCompany Announcements
Pfizer’s Ongoing Study on COMIRNATY Vaccine Safety in Youth: Key Insights for Investors
10h ago
PFE
Pfizer’s Vizimpro Post Marketing Study: A Key Update for Investors
PremiumCompany Announcements
Pfizer’s Vizimpro Post Marketing Study: A Key Update for Investors
10h ago
PFE
Pfizer’s Latest Study on COVID-19 and Influenza: Key Insights for Investors
PremiumCompany AnnouncementsPfizer’s Latest Study on COVID-19 and Influenza: Key Insights for Investors
10h ago
PFE
Pfizer’s ATGAM Study: Aiming for Safer Aplastic Anemia Treatment
Premium
Company Announcements
Pfizer’s ATGAM Study: Aiming for Safer Aplastic Anemia Treatment
10h ago
PFE
Pfizer’s Latest Clinical Study on PF-07799933: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Pfizer’s Latest Clinical Study on PF-07799933: A Potential Game-Changer in Cancer Treatment
10h ago
PFE
Pfizer’s Somatrogon Study: A Step Forward in Pediatric Growth Hormone Treatment
PremiumCompany Announcements
Pfizer’s Somatrogon Study: A Step Forward in Pediatric Growth Hormone Treatment
10h ago
PFE
Pfizer’s New Acne Treatment Study: A Potential Game-Changer?
PremiumCompany Announcements
Pfizer’s New Acne Treatment Study: A Potential Game-Changer?
10h ago
PFE
Pfizer’s Promising Phase 3 Study on Ritlecitinib for Vitiligo: Market Implications
PremiumCompany Announcements
Pfizer’s Promising Phase 3 Study on Ritlecitinib for Vitiligo: Market Implications
10h ago
PFE
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Promising Update
PremiumCompany Announcements
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Promising Update
10h ago
PFE
Pfizer’s TALZENNA Study: A Closer Look at Safety in Breast Cancer Treatment
PremiumCompany AnnouncementsPfizer’s TALZENNA Study: A Closer Look at Safety in Breast Cancer Treatment
10h ago
PFE
Pfizer’s New Cancer Study: A Potential Game-Changer for Advanced Malignancies
Premium
Company Announcements
Pfizer’s New Cancer Study: A Potential Game-Changer for Advanced Malignancies
10h ago
PFE
Pfizer’s New Study on Abrocitinib: A Potential Breakthrough for Pediatric Eczema
Premium
Company Announcements
Pfizer’s New Study on Abrocitinib: A Potential Breakthrough for Pediatric Eczema
10h ago
PFE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >